View in EDS HTML Full Text PDF Full Text

Real-world data of polatuzumab vedotin with bendamustine and rituximab for Japanese relapsed and refractory DLBCL: a multicenter retrospective study.

Saved in:

Bibliographic Details
Title:	Real-world data of polatuzumab vedotin with bendamustine and rituximab for Japanese relapsed and refractory DLBCL: a multicenter retrospective study.
Authors:	Fujino, Takahiro¹ (AUTHOR), Okamoto, Haruya¹ (AUTHOR), Nishiyama, Daichi² (AUTHOR), Hayata, Hiroki² (AUTHOR), Sasaki, Nana³ (AUTHOR), Kobayashi, Tsutomu⁴ (AUTHOR), Maekura, Chika^1,5 (AUTHOR), Kuwahara-Ota, Saeko⁶ (AUTHOR), Takimoto-Shimomura, Tomoko⁷ (AUTHOR), Shimura, Kazuho⁸ (AUTHOR), Kawaji-Kanayama, Yuka¹ (AUTHOR), Inoue, Yu¹ (AUTHOR), Chinen, Shotaro¹ (AUTHOR), Isa, Reiko^1,8 (AUTHOR), Tsukamoto, Taku¹ (AUTHOR), Mizutani, Shinsuke¹ (AUTHOR), Shimura, Yuji^1,9 (AUTHOR), Kaneko, Hiroto⁸ (AUTHOR), Nakao, Mitsushige⁷ (AUTHOR), Fuchida, Shinichi⁶ (AUTHOR)
Source:	Leukemia & Lymphoma. Aug2025, Vol. 66 Issue 8, p1425-1436. 12p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!